POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL
- PMID: 27409817
- DOI: 10.4158/EP161380.OR
POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL
Abstract
Objective: To assess the performance of biochemical markers in the detection of recurrent Cushing disease (CD), as well as the potential benefit of early intervention in recurrent CD patients with elevated late-night salivary cortisol (LNSC) and normal urinary free cortisol (UFC).
Methods: The design was a single-center, retrospective chart review. Patients treated by the authors from 2008-2013 were included. Recurrence was defined by postsurgical remission of CD with subsequent abnormal LNSC, UFC, or dexamethasone suppression test (DST).
Results: We identified 15 patients with postsurgical recurrent CD after initial remission; all but one underwent testing with LNSC, DST, and UFC. Although 12 of 15 patients had normal UFC at time of recurrence, DST was abnormal in 11 of 15, and all 14 patients with LNSC results had ≥1 elevated measurement. Nine patients (7 with normal UFC) showed radiologic evidence of a pituitary tumor at time of recurrence. Among the 14 patients with available follow-up data, 12 have demonstrated significant improvement since receiving treatment. Five patients underwent repeat pituitary surgery and 4 achieved clinical and biochemical remission. Eight patients received mifepristone or cabergoline, and 6 showed clinical and/or biochemical improvement. Three patients (2 with prior mifepristone) underwent bilateral adrenalectomy and 2 demonstrated significant clinical improvements.
Conclusion: LNSC is more sensitive than UFC or DST for detection of CD recurrence. Prompt intervention when LNSC is elevated, despite normal UFC, may yield significant clinical benefit for many patients with CD. Early treatment for patients with recurrent CD should be prospectively evaluated, utilizing LNSC elevation as an early biochemical marker.
Abbreviations: ACTH = adrenocorticotropic hormone CD = Cushing disease CS = Cushing syndrome CV = coefficient of variation DST = dexamethasone suppression test IPSS = inferior petrosal sinus sampling LNSC = late-night salivary cortisol QoL = quality of life TSS = transsphenoidal adenoma resection UFC = urinary free cortisol.
Comment in
-
THE CHALLENGE OF EARLY DIAGNOSIS OF CUSHING DISEASE RECURRENCE!Endocr Pract. 2016 Nov;22(11):1356-1357. doi: 10.4158/EP161600.CO. Epub 2016 Oct 17. Endocr Pract. 2016. PMID: 27749130 No abstract available.
Similar articles
-
Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.Clin Endocrinol (Oxf). 2015 Feb;82(2):260-6. doi: 10.1111/cen.12534. Epub 2014 Jul 25. Clin Endocrinol (Oxf). 2015. PMID: 24975391
-
Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients.J Clin Endocrinol Metab. 2022 Jan 1;107(1):205-218. doi: 10.1210/clinem/dgab659. J Clin Endocrinol Metab. 2022. PMID: 34478542 Free PMC article.
-
Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.J Clin Endocrinol Metab. 2015 Oct;100(10):3770-7. doi: 10.1210/jc.2015-2107. Epub 2015 Jul 21. J Clin Endocrinol Metab. 2015. PMID: 26196950
-
Negative surgical exploration in patients with Cushing's disease: benefit of two-thirds gland resection on remission rate and a review of the literature.J Neurosurg. 2018 Nov 1;129(5):1260-1267. doi: 10.3171/2017.5.JNS162901. J Neurosurg. 2018. PMID: 29219752 Review.
-
AN INDIVIDUALIZED APPROACH TO THE EVALUATION OF CUSHING SYNDROME.Endocr Pract. 2017 Jun;23(6):726-737. doi: 10.4158/EP161721.RA. Endocr Pract. 2017. PMID: 28614036 Review.
Cited by
-
Consensus on diagnosis and management of Cushing's disease: a guideline update.Lancet Diabetes Endocrinol. 2021 Dec;9(12):847-875. doi: 10.1016/S2213-8587(21)00235-7. Epub 2021 Oct 20. Lancet Diabetes Endocrinol. 2021. PMID: 34687601 Free PMC article. Review.
-
Medical Therapy with Pasireotide in Recurrent Cushing's Disease: Experience of Patients Treated for At Least 1 Year at a Single Center.Front Endocrinol (Lausanne). 2017 Feb 27;8:35. doi: 10.3389/fendo.2017.00035. eCollection 2017. Front Endocrinol (Lausanne). 2017. PMID: 28289402 Free PMC article.
-
Going beyond the mean in examining relationships of adolescent non-cognitive skills with health-related quality of life and biomarkers in later-life.Econ Hum Biol. 2020 Dec;39:100923. doi: 10.1016/j.ehb.2020.100923. Epub 2020 Sep 2. Econ Hum Biol. 2020. PMID: 32919376 Free PMC article.
-
Cushing's Disease.J Clin Med. 2019 Nov 12;8(11):1951. doi: 10.3390/jcm8111951. J Clin Med. 2019. PMID: 31726770 Free PMC article. Review.
-
Hypercortisolemia Recurrence in Cushing's Disease; a Diagnostic Challenge.Front Endocrinol (Lausanne). 2019 Nov 8;10:740. doi: 10.3389/fendo.2019.00740. eCollection 2019. Front Endocrinol (Lausanne). 2019. PMID: 31787930 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources